Identification of testicular cancer with T2-weighted MRI-based radiomics and automatic machine learning

Background Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to inv...

Full description

Saved in:
Bibliographic Details
Published in:BMC cancer Vol. 25; no. 1; pp. 563 - 11
Main Authors: Wang, Liang, Zhang, PeiPei, Feng, Yanhui, Lv, Wenzhi, Min, Xiangde, Liu, Zhiyong, Li, Jin, Feng, Zhaoyan
Format: Journal Article
Language:English
Published: London BioMed Central 28.03.2025
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1471-2407, 1471-2407
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization. Methods Retrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results. Results Utilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985–0.993) and 0.909 (95% CI: 0.893–0.923) in the training and testing cohorts, respectively. Conclusions AutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions.
AbstractList BackgroundDistinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization.MethodsRetrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results.ResultsUtilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985–0.993) and 0.909 (95% CI: 0.893–0.923) in the training and testing cohorts, respectively.ConclusionsAutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions.
Background Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization. Methods Retrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results. Results Utilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985-0.993) and 0.909 (95% CI: 0.893-0.923) in the training and testing cohorts, respectively. Conclusions AutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions. Keywords: Automatic machine learning, Magnetic resonance imaging, Radiomics, Testicular cancer
Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization. Retrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results. Utilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985-0.993) and 0.909 (95% CI: 0.893-0.923) in the training and testing cohorts, respectively. AutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions.
Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization.BACKGROUNDDistinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization.Retrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results.METHODSRetrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results.Utilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985-0.993) and 0.909 (95% CI: 0.893-0.923) in the training and testing cohorts, respectively.RESULTSUtilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985-0.993) and 0.909 (95% CI: 0.893-0.923) in the training and testing cohorts, respectively.AutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions.CONCLUSIONSAutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions.
Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization. Retrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results. Utilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985-0.993) and 0.909 (95% CI: 0.893-0.923) in the training and testing cohorts, respectively. AutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions.
Background Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization. Methods Retrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results. Results Utilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985–0.993) and 0.909 (95% CI: 0.893–0.923) in the training and testing cohorts, respectively. Conclusions AutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions.
Abstract Background Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However, conventional MRI-based radiomics to identify testicular cancer requires expert machine learning knowledge. This study aims to investigate the potential of utilizing automatic machine learning (AutoML) based on MRI to diagnose testicular lesions without the need for expert algorithm optimization. Methods Retrospective preoperative MRI scans from 115 patients diagnosed with testicular disease through pathology were obtained. A total of 1781 radiomics features were extracted from each lesion on the T2-weighted images. Intraclass and interclass correlation coefficients were used to evaluate the intra-observer and interobserver agreements for each radiomics feature. We developed an AutoML method based on the tree-based pipeline optimization tool (TPOT) algorithm to construct a discriminant model. The best pipeline was determined through 100 repeated operations using a 5-fold cross-validation algorithm in TPOT. The model was evaluated for accuracy, sensitivity, and specificity using the area under the curve (AUC) value of the receiver operating characteristic (ROC) curve. Shapley Additive exPlanations were used to illustrate the optimization results. Results Utilizing the TPOT method, 100 diagnostic models were developed to identify testicular lesions. The best model was determined based on the highest AUC in the training cohort. The prediction model yielded AUC values of 0.989 (95% confidence interval [CI]: 0.985–0.993) and 0.909 (95% CI: 0.893–0.923) in the training and testing cohorts, respectively. Conclusions AutoML, based on the TPOT algorithm, holds potential as a noninvasive method for effectively discriminating between benign and malignant testicular lesions.
ArticleNumber 563
Audience Academic
Author Liu, Zhiyong
Lv, Wenzhi
Feng, Zhaoyan
Zhang, PeiPei
Feng, Yanhui
Min, Xiangde
Wang, Liang
Li, Jin
Author_xml – sequence: 1
  givenname: Liang
  surname: Wang
  fullname: Wang, Liang
  organization: Computer Center, Tongji Hospital, Tongji Medical College, Uazhong University of Science and Technology
– sequence: 2
  givenname: PeiPei
  surname: Zhang
  fullname: Zhang, PeiPei
  organization: Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 3
  givenname: Yanhui
  surname: Feng
  fullname: Feng, Yanhui
  organization: Computer Center, Tongji Hospital, Tongji Medical College, Uazhong University of Science and Technology, School of Medicine and Health Management, Huazhong University of Science and Technology
– sequence: 4
  givenname: Wenzhi
  surname: Lv
  fullname: Lv, Wenzhi
  organization: Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Britton Chance Center, MoE Key Laboratory for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology
– sequence: 5
  givenname: Xiangde
  surname: Min
  fullname: Min, Xiangde
  organization: Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 6
  givenname: Zhiyong
  surname: Liu
  fullname: Liu, Zhiyong
  organization: School of Medicine and Health Management, Huazhong University of Science and Technology
– sequence: 7
  givenname: Jin
  surname: Li
  fullname: Li, Jin
  email: lijin@tjh.tjmu.edu.cn
  organization: Computer Center, Tongji Hospital, Tongji Medical College, Uazhong University of Science and Technology
– sequence: 8
  givenname: Zhaoyan
  surname: Feng
  fullname: Feng, Zhaoyan
  email: fzm198822@126.com
  organization: Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40155850$$D View this record in MEDLINE/PubMed
BookMark eNp9kltr3DAQhU1JaS7tH-hDMRRK--BUsmRZfgyhl4WUQpo-i7E89mqxpVSSSfvvK--mSTaUoAcJ8Z0zmtE5zg6ss5hlryk5pVSKj4GWUlYFKauCMsl5wZ5lR5TXtCg5qQ8enA-z4xA2hNBaEvkiO-SEVpWsyFE2rDq00fRGQzTO5q7PI4Zo9DyCzzVYjT6_MXGdX5XFDZphHbHLv12uihZCOnnojJuMDjnYLoc5uikZ6XwCvTYW8xHBW2OHl9nzHsaAr273k-zn509X51-Li-9fVudnF4UWtIlFLyU2ArnQTdcx7JqeYMMZ79uOMhS1AN6SEkpKkAAHIilnfd9y0RCCVVmzk2y18-0cbNS1NxP4P8qBUdsL5wcFPj1wRCUg-WmNNWspF5KDrFkJdafLRuhWY_J6v_O69u7XnKaiJhM0jiNYdHNQjEomaiYITejbR-jGzd6mTheqripKK3ZPDZDqG9u76EEvpupMMkYpFeVCnf6HSqvDNOgUgd6k-z3Bhz1BYiL-jgPMIajVj8t99t0Ddo0wxnVw47x8ftgH39x2NLcTdnej_BedBJQ7QHsXgsf-DqFELflUu3yqlE-1zadaXOUjkTZxm7zUoxmflrKdNKQ6dkB_P-InVH8BBNv05w
CitedBy_id crossref_primary_10_59324_ejtas_2025_3_3__10
Cites_doi 10.3390/cancers14163882
10.1038/s41598-021-83023-4
10.1002/jmri.27910
10.1158/0008-5472.CAN-17-0339
10.1145/2908812.2908918
10.1038/nrurol.2016.164
10.1016/j.ejrad.2019.02.032
10.3322/caac.21660
10.1007/s00330-017-4944-3
10.1148/radiol.14132718
10.1007/s00330-019-06495-z
10.1007/s00261-018-1560-x
10.1148/ryai.2020200029
10.4103/aja202158
10.1016/j.crad.2017.10.007
10.1148/rg.2018170150
10.1002/hbm.25028
10.1016/j.ejrad.2022.110158
10.4103/aja.aja_119_18
10.3390/jpm11100978
10.1111/andr.13032
10.3390/diagnostics12112733
10.1186/s13058-022-01516-0
10.1038/ncomms5006
10.1007/s00261-020-02621-4
10.3322/caac.21763
10.1117/1.JBO.28.4.045001
10.1002/jso.25203
10.1093/brain/awab340
10.1038/s42256-023-00717-2
10.3389/fonc.2019.01330
10.3389/fonc.2022.963612
10.1007/s00330-017-5013-7
10.3390/curroncol29100542
10.1007/s13244-017-0592-z
10.1002/jmri.27690
10.3174/ajnr.A6621
10.1093/bioinformatics/btz470
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.1186/s12885-025-13844-3
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE

MEDLINE - Academic




Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 11
ExternalDocumentID oai_doaj_org_article_6a676cce73b14684a8732a7dc296cbce
A833111623
40155850
10_1186_s12885_025_13844_3
Genre Journal Article
GeographicLocations China
United States--US
GeographicLocations_xml – name: China
– name: United States--US
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 62072349; 82001787; 81801668
– fundername: Knowledge Innovation Program of Wuhan-Shuguang Project
– fundername: National Natural Science Foundation of China
  grantid: 62072349
– fundername: National Natural Science Foundation of China
  grantid: 81801668
– fundername: National Natural Science Foundation of China
  grantid: 82001787
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
LGEZI
LOTEE
M1P
M48
M~E
NADUK
NXXTH
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
AFFHD
CITATION
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c619t-f88e96e46c9dd3ed9f0e9434fbd13e676a4b02a210e0a4a08143ffb46900e5273
IEDL.DBID RSV
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001456019900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1471-2407
IngestDate Mon Nov 10 04:31:46 EST 2025
Fri Sep 05 17:51:26 EDT 2025
Tue Oct 07 05:38:38 EDT 2025
Sat Nov 29 13:51:44 EST 2025
Tue Nov 04 18:20:40 EST 2025
Thu Nov 13 15:58:13 EST 2025
Thu May 22 21:23:43 EDT 2025
Mon Jul 21 06:02:41 EDT 2025
Sat Nov 29 08:05:13 EST 2025
Tue Nov 18 20:58:04 EST 2025
Sat Sep 06 07:29:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Automatic machine learning
Magnetic resonance imaging
Testicular cancer
Radiomics
Language English
License 2025. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c619t-f88e96e46c9dd3ed9f0e9434fbd13e676a4b02a210e0a4a08143ffb46900e5273
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://link.springer.com/10.1186/s12885-025-13844-3
PMID 40155850
PQID 3187551153
PQPubID 44074
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_6a676cce73b14684a8732a7dc296cbce
proquest_miscellaneous_3183673601
proquest_journals_3187551153
gale_infotracmisc_A833111623
gale_infotracacademiconefile_A833111623
gale_incontextgauss_ISR_A833111623
gale_healthsolutions_A833111623
pubmed_primary_40155850
crossref_primary_10_1186_s12885_025_13844_3
crossref_citationtrail_10_1186_s12885_025_13844_3
springer_journals_10_1186_s12885_025_13844_3
PublicationCentury 2000
PublicationDate 2025-03-28
PublicationDateYYYYMMDD 2025-03-28
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-28
  day: 28
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC cancer
PublicationTitleAbbrev BMC Cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2025
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References Y Li (13844_CR20) 2022; 29
H Zhou (13844_CR25) 2020; 41
C Fan (13844_CR21) 2022; 148
J Meng (13844_CR27) 2023; 28
L Manganaro (13844_CR35) 2018; 28
J Yu (13844_CR11) 2022; 24
A Luzurier (13844_CR12) 2018; 73
J Gu (13844_CR19) 2022; 12
GC Parenti (13844_CR31) 2018; 9
KP Dieckmann (13844_CR4) 2011; 34
13844_CR16
M Khanna (13844_CR34) 2021; 46
J Dafflon (13844_CR23) 2020; 41
G Song (13844_CR6) 2019; 21
13844_CR39
T Bian (13844_CR32) 2022; 55
AC Tsili (13844_CR7) 2018; 28
13844_CR13
G Li (13844_CR18) 2022; 145
TT Le (13844_CR24) 2020; 36
J Pan (13844_CR33) 2021; 54
G Feliciani (13844_CR37) 2021; 11
M Chovanec (13844_CR5) 2016; 13
AC Tsili (13844_CR9) 2021; 9
AS Tejani (13844_CR30) 2023; 5
J Bergstra (13844_CR40) 2012; 13
RL Siegel (13844_CR2) 2023; 73
S Ramanathan (13844_CR3) 2018; 43
AM Isidori (13844_CR10) 2014; 273
M Xu (13844_CR36) 2019; 114
H Sung (13844_CR1) 2021; 71
13844_CR26
13844_CR29
B Baessler (13844_CR22) 2020; 30
JJM van Griethuysen (13844_CR28) 2017; 77
HJ Aerts (13844_CR15) 2014; 5
PK Mittal (13844_CR14) 2018; 38
S Lagabrielle (13844_CR8) 2018; 118
P Zhang (13844_CR38) 2019; 9
X Wang (13844_CR17) 2022; 24
References_xml – ident: 13844_CR13
  doi: 10.3390/cancers14163882
– volume: 11
  start-page: 3456
  issue: 1
  year: 2021
  ident: 13844_CR37
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-83023-4
– volume: 13
  start-page: 281
  issue: 1
  year: 2012
  ident: 13844_CR40
  publication-title: J Mach Learn Res
– volume: 55
  start-page: 772
  issue: 3
  year: 2022
  ident: 13844_CR32
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.27910
– volume: 77
  start-page: e104
  issue: 21
  year: 2017
  ident: 13844_CR28
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-0339
– ident: 13844_CR39
  doi: 10.1145/2908812.2908918
– volume: 13
  start-page: 663
  issue: 11
  year: 2016
  ident: 13844_CR5
  publication-title: Nat Rev Urol
  doi: 10.1038/nrurol.2016.164
– volume: 114
  start-page: 38
  year: 2019
  ident: 13844_CR36
  publication-title: Eur J Radiol
  doi: 10.1016/j.ejrad.2019.02.032
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: 13844_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 28
  start-page: 31
  issue: 1
  year: 2018
  ident: 13844_CR7
  publication-title: Eur Radiol
  doi: 10.1007/s00330-017-4944-3
– volume: 273
  start-page: 606
  issue: 2
  year: 2014
  ident: 13844_CR10
  publication-title: Radiology
  doi: 10.1148/radiol.14132718
– volume: 30
  start-page: 2334
  issue: 4
  year: 2020
  ident: 13844_CR22
  publication-title: Eur Radiol
  doi: 10.1007/s00330-019-06495-z
– volume: 43
  start-page: 3125
  issue: 11
  year: 2018
  ident: 13844_CR3
  publication-title: Abdom Radiol (NY)
  doi: 10.1007/s00261-018-1560-x
– ident: 13844_CR29
  doi: 10.1148/ryai.2020200029
– volume: 24
  start-page: 201
  issue: 2
  year: 2022
  ident: 13844_CR11
  publication-title: Asian J Androl
  doi: 10.4103/aja202158
– volume: 73
  start-page: 322
  issue: 3
  year: 2018
  ident: 13844_CR12
  publication-title: Clin Radiol
  doi: 10.1016/j.crad.2017.10.007
– volume: 38
  start-page: 806
  issue: 3
  year: 2018
  ident: 13844_CR14
  publication-title: Radiographics
  doi: 10.1148/rg.2018170150
– volume: 41
  start-page: 3555
  issue: 13
  year: 2020
  ident: 13844_CR23
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.25028
– volume: 148
  start-page: 110158
  year: 2022
  ident: 13844_CR21
  publication-title: Eur J Radiol
  doi: 10.1016/j.ejrad.2022.110158
– volume: 21
  start-page: 196
  issue: 2
  year: 2019
  ident: 13844_CR6
  publication-title: Asian J Androl
  doi: 10.4103/aja.aja_119_18
– ident: 13844_CR26
  doi: 10.3390/jpm11100978
– volume: 9
  start-page: 1395
  issue: 5
  year: 2021
  ident: 13844_CR9
  publication-title: Andrology
  doi: 10.1111/andr.13032
– ident: 13844_CR16
  doi: 10.3390/diagnostics12112733
– volume: 24
  start-page: 20
  issue: 1
  year: 2022
  ident: 13844_CR17
  publication-title: Breast Cancer Res
  doi: 10.1186/s13058-022-01516-0
– volume: 5
  start-page: 4006
  year: 2014
  ident: 13844_CR15
  publication-title: Nat Commun
  doi: 10.1038/ncomms5006
– volume: 46
  start-page: 319
  issue: 1
  year: 2021
  ident: 13844_CR34
  publication-title: Abdom Radiol (NY)
  doi: 10.1007/s00261-020-02621-4
– volume: 73
  start-page: 17
  issue: 1
  year: 2023
  ident: 13844_CR2
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21763
– volume: 28
  start-page: 045001
  issue: 4
  year: 2023
  ident: 13844_CR27
  publication-title: J Biomed Opt
  doi: 10.1117/1.JBO.28.4.045001
– volume: 118
  start-page: 630
  issue: 4
  year: 2018
  ident: 13844_CR8
  publication-title: J Surg Oncol
  doi: 10.1002/jso.25203
– volume: 145
  start-page: 1151
  issue: 3
  year: 2022
  ident: 13844_CR18
  publication-title: Brain
  doi: 10.1093/brain/awab340
– volume: 5
  start-page: 950
  issue: 9
  year: 2023
  ident: 13844_CR30
  publication-title: Nat Mach Intell
  doi: 10.1038/s42256-023-00717-2
– volume: 9
  start-page: 1330
  year: 2019
  ident: 13844_CR38
  publication-title: Front Oncol
  doi: 10.3389/fonc.2019.01330
– volume: 12
  start-page: 963612
  year: 2022
  ident: 13844_CR19
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.963612
– volume: 34
  start-page: e7
  issue: 4 Pt 2
  year: 2011
  ident: 13844_CR4
  publication-title: Int J Androl
– volume: 28
  start-page: 554
  issue: 2
  year: 2018
  ident: 13844_CR35
  publication-title: Eur Radiol
  doi: 10.1007/s00330-017-5013-7
– volume: 29
  start-page: 6893
  year: 2022
  ident: 13844_CR20
  publication-title: Curr Oncol
  doi: 10.3390/curroncol29100542
– volume: 9
  start-page: 137
  issue: 2
  year: 2018
  ident: 13844_CR31
  publication-title: Insights Imaging
  doi: 10.1007/s13244-017-0592-z
– volume: 54
  start-page: 1314
  issue: 4
  year: 2021
  ident: 13844_CR33
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.27690
– volume: 41
  start-page: 1279
  issue: 7
  year: 2020
  ident: 13844_CR25
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A6621
– volume: 36
  start-page: 250
  issue: 1
  year: 2020
  ident: 13844_CR24
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btz470
SSID ssj0017808
Score 2.4398348
Snippet Background Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment...
Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment planning. However,...
Background Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment...
BackgroundDistinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding treatment...
Abstract Background Distinguishing between benign and malignant testicular lesions on clinical magnetic resonance imaging (MRI) is crucial for guiding...
SourceID doaj
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 563
SubjectTerms Accuracy
Adolescent
Adult
Aged
Algorithms
Artificial intelligence
Automatic machine learning
Biomedical and Life Sciences
Biomedicine
Biopsy
Breast cancer
Cancer Research
Diagnosis
Feature selection
Genetic algorithms
Glioma
Health aspects
Health Promotion and Disease Prevention
Humans
Learning algorithms
Lesions
Machine Learning
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Male
Medicine/Public Health
Methods
Middle Aged
Oncology
Optimization
Patients
Prediction models
Radiomics
Radiomics in cancer diagnosis and treatment
Reproducibility
Retrospective Studies
ROC Curve
Sensitivity analysis
Sensitivity and Specificity
Statistical analysis
Surgery
Surgical Oncology
Technology application
Testes
Testicular cancer
Testicular Neoplasms - diagnosis
Testicular Neoplasms - diagnostic imaging
Testicular Neoplasms - pathology
Tumors
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXVN6BAgYhcYCoju1N7GNBVPTQCpUi9WY5trOqBAnaZMvfZ8ZxQgMCLlw34yg7b9sz3xDyUivta8hUc6dZnUvuXW55qcHweMN50dS1dHHYRHVyos7P9ccro76wJmyEBx4Zt1_asiqdC5WosUtIWlUJbivvuC5d7QJ6X1bpaTOV7g8qxdTUIqPK_R68sMJO5BVi7kmZi0UYimj9v_vkK0Hpl1vSGHwOd8mtlDXSg_Frb5Nrob1Dbhyne_G7ZD322zbpAI52DR0QPiMWmVKHkt1QPHKlZzz_Hk9Dg6fHp0c5RjFPN9ZfYHtyT23rqd0OXURypV9jqWWgabbE-h75fPj-7N2HPI1QyB3sjIa8USroMsjSae9F8LphARHhmtoXIgBnrawZt7DvC8xKC_mBFE1T456ZBcRmu0922q4NDwldIaQ5pENehwIiGsoWchUvV0UdpNQiI8XEUeMSvjiOufhi4j5DlWaUggEpmCgFA2tez2u-jegaf6V-i4KaKREZO_4A-mKSvph_6UtGnqGYzdhmOtu3OVBCgN-HbDAjLyIFomO0WH6zttu-N0efThdErxJR08G_dDZ1MwCvEFBrQbm3oATzdcvHk76Z5D56A462AmZDNMrI8_kxrsSSuDZ020gjsCiPFRl5MOrpzBmJmbBasYy8mRT358v_zOBH_4PBj8lNjobGRM7VHtkZNtvwhFx3l8NFv3kazfQHdps69w
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELWgINQL35RAAYOQOIDVxPEm9gkVREUPrVAp0t4sx3ZWlSApSRb-PjOOk7IgeuG6Ga8S-3lmPJ55Q8hLJZWrwFNlVqUVE9xZZnihYOPxmvOsriphQ7OJ8vhYLpfqUwy49TGtctKJQVG71mKMfA-wV4J1hw369vw7w65ReLsaW2hcJdewbTbivFzOB66slKmcCmVksdeDLpZYj7xA5j0hWL5hjAJn_9-a-TfT9MddaTBBB7f-9-Vvk5vR-aT7I1rukCu-uUtuHMXr9XtkNZbt1jGOR9uaDsjCEXJVqUWAdBQjt_SUs58hqOodPTo5ZGgMHe2MO8Mq556axlGzHtpACEu_hYxNT2OLitV98uXgw-n7jyx2YmAWDlgDq6X0qvCisMq53DtVpx6J5erKZbkvysKIKuUGjo8-NcKAmyHyuq7w6J16pHh7QLaatvEPCV0gMzp4VU75DAwjQgRcHicWWeWFUHlCsmlJtI005dgt46sOxxVZ6HEZNSyjDsuoYczrecz5SNJxqfQ7XOlZEgm2ww9tt9Jxv-rCwFdZ68u8wuI0YQBd3JTOclXYyvqEPEOc6LFadVYTel_mOZgPcCoT8iJIIMlGg1k8K7Pue334-WRD6FUUqlv4SmtiUQTMFfJybUjubkiCFrCbjyfk6aiFen0Bu4Q8nx_jSMysa3y7DjI55valWUJ2RqDPMyPQoZaLNCFvJuRf_Pm_J_jR5e_ymGxz3INpzrjcJVtDt_ZPyHX7Yzjru6dhB_8CyOVIYw
  priority: 102
  providerName: ProQuest
Title Identification of testicular cancer with T2-weighted MRI-based radiomics and automatic machine learning
URI https://link.springer.com/article/10.1186/s12885-025-13844-3
https://www.ncbi.nlm.nih.gov/pubmed/40155850
https://www.proquest.com/docview/3187551153
https://www.proquest.com/docview/3183673601
https://doaj.org/article/6a676cce73b14684a8732a7dc296cbce
Volume 25
WOSCitedRecordID wos001456019900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature - Connect here FIRST to enable access
  customDbUrl:
  eissn: 1471-2407
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017808
  issn: 1471-2407
  databaseCode: RSV
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbYXYS48H4ElmIQEgc2IondxD7uol3RQ6uqu6ByshzbqVaCBDUt_H1mHCdQXhJcIiUZR8lkXrZnviHkhRTSlhCpxkYmZcwza2Kd5RIUL6uyLK3KkhvfbKKYzcRyKeehKKzts937LUlvqb1ai_x1C5ZUYDXxGHHzOI_ZHjkAdyewYcPi_P2wd1CIRPTlMb8dt-OCPFL_r_b4B4f00w6pdzxnN__vlW-RGyHQpMedZNwmV1x9h1ybhq30u2TVlehWYc2ONhXdIOKGz0ulBoVhTXGVll5k8Ve_gOosnS4mMTo-S9faXmJFc0t1banebhoP_ko_-exMR0M7itU98u7s9OLN2zh0XYgNTKY2cSWEk7njuZHWMmdllTgEkatKmzKXF7nmZZJpmCq6RHMNIQVnVVXiNDtxCOd2n-zXTe0eEjpGFHSIoKx0KThBFAcIbywfp6XjXLKIpP2PUCZAkmNnjI_KT01ErjoOKuCg8hxUMObVMOZzB8jxV-oT_L8DJYJp-wvNeqWCbqpcw1cZ4wpWYiEa16JgmS6syWRuSuMi8hSlQ3WVqYNJUMeCMXAVEEBG5LmnQECNGjN2VnrbtmpyvtghehmIqga-0uhQAAG8QgyuHcrDHUrQeLN7uxdTFSxOq8A2F8BscGAReTbcxpGYRVe7ZutpGObxJWlEHnTiPXCGY_AsxklEjnpZ_v7wPzP40b-RPybXM1SHhMWZOCT7m_XWPSFXzZfNZbsekb1iWfijGJGDk9PZfDHyiyRwNp9M5x9GXtO_AQEQRMA
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcCF9yNQqEEgDmA1cbyJc0CoPKqu2l2hspX2ZhzbWVWCpGx2qfhT_EZmnEdZEL31wDUZR7HzzYzHmfmGkGeZzGwOO1VmsjBnglvDNE8yUDxecB4VeS6MbzaRjsdyOs0-rpGfXS0MplV2NtEbalsZPCPfAuyl4N1BQd8cf2PYNQr_rnYtNBpY7LkfJxCy1a-H7-H7Pud858Pk3S5ruwowA8HCghVSuixxIjGZtbGzWRE6JEkrchvFLkkTLfKQawiFXKiFBpcp4qLIMYwMHdKVwXMvkItgx1MM9tJpH-BFqQxlV5gjk60abL_E-ucBMv0JweIV5-d7BPztCX5zhX_8m_Uub-f6_7ZYN8i1dnNNtxttuEnWXHmLXB616QO3yawpSy7ac0paFXSBLCM-F5caVIA5xZNpOuHsxB8aO0tHB0OGzt7SubZHWMVdU11aqpeLyhPe0q8-I9XRtgXH7A45PJdp3iXrZVW6-4QOkPkddo02cxE4flQB2NJZMYhyJ0QWByTqIKBMS8OO3UC-KB-OyUQ1sFEAG-Vho2DMy37McUNCcqb0W0RWL4kE4v5CNZ-p1h6pRMOsjHFpnGPxndAyjblOreFZYnLjArKJuFRNNW5vBtW2jGNwj7BpDshTL4EkIiVmKc30sq7V8NPBitCLVqioYJZGt0UfsFbIO7YiubEiCVbOrN7ukK5aK1urU5gH5El_G0di5mDpqqWXiTF3MYwCcq9RrH5lBAYMchAG5FWnaacP__cCPzj7XTbJld3JaF_tD8d7D8lVjvofxozLDbK-mC_dI3LJfF8c1fPH3npQ8vm8NfAXQnKlEQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagoIoXbmigUIOQeKBRE9ub2I_lWLGCrqq2oL5Zjo9VJZpUSRb-Ph7noOGSEK_xOErGc9oznxF6IbgwhY9UYy2SImbE6FiRTHjFI46Q1BUF0-GyiXy55Ken4vBSF3-odh-OJLueBkBpKtu9C-M6FefZXuOtKofO4hlg6DEW06voGoNCesjXjz-P5wg5T_jQKvPbeRN3FFD7f7XNl5zTT6elwQnNb_3_599GN_sAFO93EnMHXbHlXbR50B-x30OrrnXX9Xt5uHK4BSSOUK-KNQhJjWH3Fp-Q-FvYWLUGHxwtYnCIBtfKnEGnc4NVabBat1UAhcXnoWrT4v6aitV99Gn-7uTN-7i_jSHWPslqY8e5FZllmRbGUGuESyyAy7nCpNRmeaZYkRDlU0ibKKZ8qMGocwWk34kFmLcHaKOsSruF8AzQ0X1kZYRNvXMEMfFhj2GztLCMCRqhdFgUqXuocrgx44sMKQvPZMdB6TkoAweln_NqnHPRAXX8lfo1rPVICSDb4UFVr2SvszJT_q-0tjktoEGNKZ5TonKjich0oW2EdkBSZNexOpoKuc8p9S7EB5YReh4oAGijhEqelVo3jVwcH02IXvZErvJ_qVXfGOF5BdhcE8rtCaW3BHo6PIis7C1RI73Nzj2zvWOL0LNxGGZCdV1pq3WgoVDfl6QRetiJ-sgZBkE1nyUR2h3k-sfL_8zgR_9GvoM2D9_O5cfF8sNjdIOAZiQ0JnwbbbT12j5B1_XX9qypnwb1_g4slUp4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+testicular+cancer+with+T2-weighted+MRI-based+radiomics+and+automatic+machine+learning&rft.jtitle=BMC+cancer&rft.au=Wang%2C+Liang&rft.au=Zhang%2C+PeiPei&rft.au=Feng%2C+Yanhui&rft.au=Lv%2C+Wenzhi&rft.date=2025-03-28&rft.eissn=1471-2407&rft.volume=25&rft.issue=1&rft.spage=563&rft_id=info:doi/10.1186%2Fs12885-025-13844-3&rft_id=info%3Apmid%2F40155850&rft.externalDocID=40155850
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon